Numerous studies have reported that increased expression of S100B, an intracellular Ca2+ receptor protein and secreted neuropeptide, exacerbates Alzheimer's disease (AD) pathology. The gene discussed is NPS; the disease is early-onset autosomal dominant Alzheimer disease.